Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico city

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 4, 2010, Pages 261-270

  Cruz, M ^a   Valladares Salgado, A ^a   Garcia Mena, J ^b   Ross, K ^c   Edwards, M ^c   Angeles Martinez, J ^a   Ortega Camarillo, C ^a   Escobedo De La Pena J ^d   Burguete Garcia, A I ^e   Wacher Rodarte, N ^a   Ambriz, R ^d   Rivera, R ^d   D'Artote, A L ^d   Peralta, J ^a   Parra, Esteban J ^c   Kumate, J ^d  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Ancestry informative markers; Candidate genes; Metabolic syndrome; Mexican population; Type 2 diabetes

Indexed keywords

ADRB3 PROTEIN; CDKAL1 PROTEIN; ENPP1 PROTEIN; FTO PROTEIN; HHEX PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; LEPR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; SIRTUIN 1; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 77952753961     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1082     Document Type: Article

References (70)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(suppl 1): S5-S20. [PubMed: 2502614].
2. Florez JC. The genetics of Type 2 diabetes: a realistic appraisal. J Clin Endocrinol Metab 2008; 93: 4633-4642. [PubMed: 18782870].
3. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003; 29: 6S9-6S18. [PubMed: 14502096].
4. Rull JA, Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gómez- Pérez FJ, Olaiz G. Epidemiology of Type 2 diabetes in Mexico. Arch Med Res 2005; 36: 188-196. [PubMed: 15925009].
5. Olaiz FG, Rivera J, Shamah L, et al. Encuesta Nacional de Salud y Nutrición. Instituto Nacional de Salud Publica, 2006; 17-121.
6. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med 1998; 15: 539-553. [PubMed: 9686693].
7. Zimmet P, Alberti G, Serrano-Ríos M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol 2005; 58: 1371-1376. [PubMed: 16371194].
8. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis andmanagement of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752. [PubMed: 16157765].
9. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am 2008; 37: 581-601. [PubMed: 18775353].
10. Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr 2009; 49: 442-449. [PubMed: 19644391].
11. Gonzalez-Sarmiento E, Pascual-Calleja I, Laclaustra-Gimeno M, Casasnovas-Lenguas J. Metabolic syndrome and diabetes mellitus. Rev Esp Cardiol 2005; 5(Suppl D): 30-37.
12. Florez JC, Manning AK, Dupuis J, et al. A 100K genomewide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 2007; 56: 3063-3074. [PubMed: 17848626].
13. Salonen JT, Uimari P, Aalto JM, et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet 2007; 81: 338-345. [PubMed: 17668382].
14. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345. [PubMed: 17463248].
15. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-885. [PubMed: 17293876].
16. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007; 39: 770-775. [PubMed: 17460697].
17. Saxena R, Voight BF, Lyssenko V, et al. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316: 1331-1336. [PubMed: 17463246].
18. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678. [PubMed: 17554300].
19. Zeggini E, Weedon MN, Lindgren CM, et al. Wellcome Trust Case Control Consortium (WTCCC). Replication of genomewide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-1341. [PubMed: 17463249].
20. Zeggini E, Scott LJ, Scott LJ, et al. Wellcome Trust Case Control Consortium. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40: 638-645. [PubMed: 18372903].
21. Unoki H, Takahashi A, Kawaguchi T, et al. Maeda SSNPs in KCNQ1 are associated with susceptibility to Type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40: 1098-1102. [PubMed: 18711366].
22. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to Type 2 diabetes mellitus. Nat Genet 2008; 40: 1092-1097. [PubMed: 18711367].
23. Grarup N, Urhammer SA, Ek J, et al. Studies of the relationship between the ENPP1 K121Q polymorphism and Type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia 2006; 49: 2097-2104. [PubMed: 16865358].
24. Meyre D, Bouatia-Naji N, Vatin V, et al. ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia 2007; 50: 2090-2096. [PubMed: 17704904].
25. Stolerman ES, Manning AK, McAteer JB, et al. Haplotype structure of the ENPP1 gene and nominal association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes 2008; 57: 1971-1977. [PubMed: 18426862].
26. Marvelle AF, Lange LA, Qin L, Adair LS, Mohlke KL. Association of FTO with obesity-related traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort. Diabetes 2008; 57: 1987-1991. [PubMed: 18426866].
27. Morcillo S, Cardona F, Rojo-Martínez G, et al. Effect of the combination of the variants-75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). Clin Endocrinol (Oxf) 2008; 68: 102-107. [PubMed: 17727676].
28. Salopuro T, Pulkkinen L, Lindström J, et al. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight. Int J Obes (Lond) 2005; 29: 1245-1251. [PubMed: 15997246].
29. Han HR, Ryu HJ, Cha HS, et al. Genetic variations in the leptin and leptin receptor genes are associated with type 2 diabetes mellitus and metabolic traits in the Korean female population. Clin Genet 2008; 74: 105-115. [PubMed: 18564365].
30. Qu Y, Yang Z, Jin F, et al. The haplotype identified in LEPR gene is associated with type 2 diabetes mellitus in Northern Chinese. Diabetes Res Clin Pract 2008; 81: 33-37. [PubMed: 18439701].
31. Souren NY, Paulussen AD, Steyls A, et al. Common SNPs in LEP and LEPR associated with birth weight and type 2 diabetes-related metabolic risk factors in twins. Int J Obes (Lond) 2008; 32: 1233-1239. [PubMed: 18490929].
32. Liang F, Kume S, Koya D. SIRT1 and insulin resistance. Nat Rev Endocrinol 2009; 5: 367-373. [PubMed: 19455179].
33. Zillikens MC, van Meurs JB, Rivadeneira F, et al. SIRT1 genetic variation is related to body mass index and risk of obesity. Diabetes 2009; 58: 2828-2834. [PubMed: 19741164].
34. McCarthy MI. Casting a wider net for diabetes susceptibility genes. Nat Genet 2008; 40: 1039-1040. [PubMed: 19165915].
35. Hayashi T, Iwamoto Y, Kaku K, Hirose H, Maeda S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese populations. Diabetologia 2007; 50: 980-984. [PubMed: 17340123].
36. Parra EJ, Cameron E, Simmonds L, et al. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City. Clin Genet 2007; 71: 359-366. [PubMed: 17470138].
37. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000; 23(suppl 1): S4-S19. [PubMed: 12017675].
38. Bonilla C, Parra EJ, Pfaff CL, et al. Admixture in the Hispanics of the San Luis Valley, Colorado, and its implications for complex trait gene mapping. Ann Hum Genet 2004; 68: 139-153. [PubMed: 15008793].
39. Bonilla C, Shriver MD, Parra EJ, Jones A, Fernandez JR. Ancestral proportions and their association with skin pigmentation and bone mineral density in Puerto Rican women from New York City. Hum Genet 2004; 115: 57-68. [PubMed: 15118905].
40. Shriver MD, Mei R, Parra EJ, et al. Largescale SNP analysis reveals clustered and continuous patterns of human genetic variation. Hum Genomics 2005; 2: 81-89. [PubMed: 16004724].
41. Hoggart CJ, Parra EJ, Shriver MD, Kittles RA, Clayton DG, McKeigue PM. Control of confounding of genetic associations in stratified populations. Am J Hum Genet 2003; 72: 1492-1504. [PubMed: 12817591].
42. Martinez-Marignac VL, Valladares A, Cameron E, et al. Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors. Hum Genet 2007; 120: 807-819. [PubMed: 17066296].
43. Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet 2007; 81: 208-227. [PubMed: 17668372].
44. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer 2004; 96: 434-442. [PubMed: 15026468].
45. Florez JC, Price AL, Campbell D, et al. Strong association of socioeconomic status with genetic ancestry in Latinos: implications for admixture studies of type 2 diabetes. Diabetologia 2009; 52: 1528-1536. [PubMed: 19526211].
46. Cauchi S, El Achhab Y, Choquet H, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 2007; 85: 777-782. [PubMed: 17476472].
47. Marzi C, Huth C, Kolz M, et al. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res 2007; 39: 46-52. [PubMed: 17226113].
48. Wegner L, Hussain MS, Pilgaard K, et al. Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins. J Clin Endocrinol Metab 2008; 93: 4013-4019. [PubMed: 18611970].
49. da Silva Xavier G, Loder MK, McDonald A, et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 2009; 58: 894-905. [PubMed: 19168596].
50. Pilgaard K, Jensen CB, Schou JH, et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 2009; 52: 1298-1307. [PubMed: 19288077].
51. Stolerman ES, Manning AK, McAteer JB, et al. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009; 52: 614-620. [PubMed: 19183934].
52. McFarlane-Anderson N, Bennett F, Wilks R, et al. The Trp64Arg mutation of the beta3-adrenergic receptor is associated with hyperglycemia and current body mass index in Jamaican women. Metabolism 1998; 47: 617-621. [PubMed: 9591756].
53. Ringel J, Kreutz R, Distler A, Sharma AM. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus. Am J Hypertens 2000; 13: 1027-1031. [PubMed: 10981554].
54. Oizumi T, Daimon M, Saitoh T, et al. Funagata Diabetes Study. Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 2001; 24: 1579-1583. [PubMed: 11522702].
55. Gjesing AP, Andersen G, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O. Association of the beta3-adrenergic receptor Trp64Arg polymorphism with commonmetabolic traits: studies of 7605 middle-aged white people. Mol Genet Metab 2008; 94: 90-97. [PubMed: 18249022].
56. Kurokawa N, Young EH, Oka Y, et al. The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond) 2008; 32: 1240-1249. [PubMed: 18574485].
57. Bracale R, Pasanisi F, Labruna G, et al. Metabolic syndrome and ADRB3 gene polymorphism in severely obese patients from South Italy. Eur J Clin Nutr 2007; 61: 1213-1219. [PubMed: 17299491].
58. Yoshida T, Yajima K, Hibino T, et al. Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles. Int J Mol Med 2007; 20: 581-590. [PubMed: 17786291].
59. Arner P, Hoffstedt J. Adrenoreceptor genes in human obesity. J Intern Med 1999; 245: 667-672. [PubMed: 10395196].
60. Bordone L, Motta MC, Picard F, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 2006; 4: e31. [PubMed: 16366736].
61. Chaudhary N, Pfluger PT. Metabolic benefits from Sirt1 and Sirt1 activators. Curr Opin Clin Nutr Metab Care 2009; 12: 431-437. [PubMed: 19474719].
62. NieY, Erion DM, Yuan Z, et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol 2009; 11: 492-500. [PubMed: 19295512].
63. Wojcik M, Mac-Marcjanek K, Wozniak LA. Physiological and pathophysiological functions of SIRT1. Mini Rev Med Chem 2009; 9: 386-394. [PubMed: 19275731].
64. Horikoshi M, Hara K, Ito C, et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 2007; 50: 2461-2466. [PubMed: 17928989].
65. Takeuchi F, Serizawa M, Yamamoto K, et al. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009; 58: 1690-1699. [PubMed: 19401414].
66. Grarup N, Rose CS, Andersson EA, et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 2007; 56: 3105-3111. [PubMed: 17827400].
67. Pascoe L, Tura A, Patel SK, et al. RISC Consortium; U.K. Type 2 Diabetes Genetics Consortium. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta cell function. Diabetes 2007; 56: 3101-3104. [PubMed: 17804762].
68. Staiger H, Machicao F, Stefan N, et al. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One 2007; 2: e832. [PubMed: 17786204].
69. Staiger H, Stancakova A, Zilinskaite J, et al. A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. Diabetes 2008; 57: 514-517. [PubMed: 18039816].
70. Ruchat SM, Elks CE, Loos RJ, et al. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 2009; 46: 217-226. [PubMed: 19082521].